JAMA Neurology Reports Phase 2b PARADIGM Trial Results in ALS
The Journal of the American Medical Association (JAMA Neurology) publication highlights consistent clinical and biomarker findings from NeuroSense PARADIGM Phase 2b trial in ALS, including...